Key result
CT-derived epicardial adipose tissue volume shows no association with CAD in adults aged 80 and older.
Why the study?
Epicardial adipose tissue is associated with CAD in middle-aged and mixed-age populations, but its discriminative value in adults aged 80 years and older remains uncertain.
Does CT-derived EAT volume improve discrimination of CAD beyond conventional risk factors in adults aged 80 years and older?
Cohort (n=155)
No
Does CT-derived EAT volume improve discrimination of CAD beyond conventional risk factors in adults aged 80 years and older?
In adults aged 80 years and older, CT-derived epicardial adipose tissue volume does not provide incremental value beyond conventional clinical risk factors for discriminating coronary artery disease.
Answers are grounded in this paper and cite their sources.
Does not support EAT measurement for CAD discrimination in adults ≥80 years; leaves open its utility in younger cohorts or with refined protocols.
Background: Epicardial adipose tissue (EAT) has been associated with coronary artery disease (CAD) in middle-aged and mixed-age populations, but its value in adults aged 80 years and older remains uncertain. This study investigated whether computed tomography (CT)-derived EAT volume provides incremental value for discriminating CAD in this very elderly population. Methods: We retrospectively included 155 patients aged ≥80 years who underwent coronary imaging evaluation between 2020 and 2022. EAT volume was quantified from non-contrast chest CT. Logistic regression, CatBoost modeling, and SHapley Additive exPlanations (SHAP) were used to assess the association of EAT with CAD, its discriminative value, and its relative contribution. Results: Forty-five patients (29.0%) had CAD. Median EAT volume did not differ between groups (p = 0.716) and was not associated with CAD after adjustment for age, sex, body mass index, diabetes, and glycated hemoglobin A1c (HbA1c). Adding EAT did not improve discrimination in logistic regression [area under the curve (AUC) 0.698 vs. 0.697; likelihood-ratio p = 0.945] or in cross-validated CatBoost analysis (AUC 0.623 vs. 0.614). SHAP ranked EAT eighth of eighteen predictors, below lipoprotein(a), total cholesterol, left atrial diameter, HbA1c, low-density lipoprotein cholesterol, diabetes, and atrial fibrillation. Conclusions: In adults aged 80 years and older, CT-derived EAT volume was not independently associated with CAD and added no discriminative value beyond conventional clinical risk factors. Total EAT volume may have limited utility as a CAD marker in very elderly adults.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a cohort in Coronary Artery Disease (n=155). Computed tomography-derived epicardial adipose tissue (EAT) volume vs. Conventional clinical risk factors was evaluated on Association of EAT volume with CAD (adjusted for age, sex, BMI, diabetes, and HbA1c) (OR 0.98, 95% CI 0.65-1.48, p=0.930). In adults aged 80 years and older, CT-derived epicardial adipose tissue volume was not independently associated with coronary artery disease and added no discriminative value.
Synapse has enriched 10 related papers. Consider them for comparative context: